AJ Lanigan: Certainly. In Truth, pharma providers are making large money with treatment options like Keytruda and Opdivo that offer with PD-one and PD-L1. Here’s the super neat section: visualize checkpoints as visitors alerts. You don’t want an immune system that’s jogging wild like a freight practice over a cliff. waiting for link from Social Bookmarking